Skip to main content
. Author manuscript; available in PMC: 2022 Jun 12.
Published in final edited form as: Angew Chem Int Ed Engl. 2021 Jun 14;60(29):15905–15911. doi: 10.1002/anie.202101328

Figure 6.

Figure 6.

In vivo pharmacodynamics study of DGY-09-192. A. Immunoblot analysis of lysates from four independent tumors from each treatment group. B. Quantification of FGFR1, FGFR2, p-FRS2 and p-ERK. (Significantly different: P < 0.05; tumor size data shown in Figure S8.)